These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 1364023
1. Peroral immunization of adult white mice with the Skalica strain from the tick-borne encephalitis virus complex. Elecková E, Gresíková M. Acta Virol; 1992 Oct; 36(5):466-72. PubMed ID: 1364023 [Abstract] [Full Text] [Related]
2. Studies on preparation of a tick-borne encephalitis (TBE) vaccine from the Skalica strain. Gresíková M, Sekeyová M, Marcinka K, Ciampor F. Acta Virol; 1986 May; 30(3):243-8. PubMed ID: 2874729 [Abstract] [Full Text] [Related]
3. To the antigenic classification of some viruses from the tick-borne encephalitis complex by monoclonal antibodies. Gresíková M, Sekeyová M. Acta Virol; 1990 Feb; 34(1):90-4. PubMed ID: 1975730 [Abstract] [Full Text] [Related]
4. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge. Goncharova E, Ryzhikov E, Poryvaev V, Bulychev L, Karpyshev N, Maksyutov A, Ryzhikov AB. Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605 [Abstract] [Full Text] [Related]
5. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus. Goncharova EP, Ryzhikov AB, Bulychev LE, Sizov AA, Lebedev LR, Poryvaev VD, Karpenko LI, Il'ichev AA. Wien Klin Wochenschr; 2002 Jul 31; 114(13-14):630-5. PubMed ID: 12422616 [Abstract] [Full Text] [Related]
6. Monoclonal antibodies to tick-borne encephalitis (TBE) virus: their use for differentiation of the TBE complex viruses. Kopecký J, Tomková E, Grubhoffer L, Melnikova YE. Acta Virol; 1991 Aug 31; 35(4):365-72. PubMed ID: 1686961 [Abstract] [Full Text] [Related]
7. Antigenic variation of the viruses belonging to the tick-borne encephalitis complex as revealed by human convalescent serum and monoclonal antibodies. Gresíkova M, Sekeyová M. Acta Virol; 1987 Mar 31; 31(2):152-7. PubMed ID: 2886024 [Abstract] [Full Text] [Related]
8. Vaccination against tick-borne encephalitis--distant evaluation. Bobrowska E, Grzeszczuk A, Prokopowicz D. Rocz Akad Med Bialymst; 1996 Mar 31; 41(1):44-50. PubMed ID: 8673804 [Abstract] [Full Text] [Related]
9. Evaluation of tick-borne encephalitis DNA vaccines in monkeys. Schmaljohn C, Custer D, VanderZanden L, Spik K, Rossi C, Bray M. Virology; 1999 Oct 10; 263(1):166-74. PubMed ID: 10544091 [Abstract] [Full Text] [Related]
10. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis. Dmitriev IP, Khromykh AA, Ignatyev GM, Gainullina MN, Ageenko VA, Dryga SA, Vorobyeva MS, Sandakhchiev LS. J Biotechnol; 1996 Jan 26; 44(1-3):97-103. PubMed ID: 8717392 [Abstract] [Full Text] [Related]
11. Tick-borne encephalitis virus transmission between ticks cofeeding on specific immune natural rodent hosts. Labuda M, Kozuch O, Zuffová E, Elecková E, Hails RS, Nuttall PA. Virology; 1997 Aug 18; 235(1):138-43. PubMed ID: 9300045 [Abstract] [Full Text] [Related]
13. Comparison of skalica, Hypr, and Langat viruses by kinetic haemagglutination-inhibition test. Elecková E, Gresíková M, Sekeyová M. Acta Virol; 1990 Apr 18; 34(2):198-201. PubMed ID: 1975983 [Abstract] [Full Text] [Related]
14. Experimental characteristics of viraemia caused by two strains of tick-borne encephalitis virus in small rodents. Kozuch O, Chunikhin SP, Gresíková M, Nosek J, Kurenkov VB, Lysý J. Acta Virol; 1981 Jul 18; 25(4):219-24. PubMed ID: 6116416 [Abstract] [Full Text] [Related]
15. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice. Pletnev AG. Virology; 2001 Apr 10; 282(2):288-300. PubMed ID: 11289811 [Abstract] [Full Text] [Related]
16. Pathogenicity of the skalica strain (from the tick-borne encephalitis complex) for white mice. Rajcáni J, Gresíková M. Acta Virol; 1982 Jul 10; 26(4):264-9. PubMed ID: 6127934 [Abstract] [Full Text] [Related]
17. A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model. Volpina OM, Volkova TD, Koroev DO, Ivanov VT, Ozherelkov SV, Khoretonenko MV, Vorovitch MF, Stephenson JR, Timofeev AV. Virus Res; 2005 Sep 10; 112(1-2):95-9. PubMed ID: 16022903 [Abstract] [Full Text] [Related]
18. Production of monoclonal antibodies with haemagglutination-inhibition activity to the Skalica strain from the tick-borne encephalitis complex. Novák M, Gresíková M, Sekeyová M, Russ G, Zikán J, Pospísil M, Ciampor F. Acta Virol; 1983 Jan 10; 27(1):34-42. PubMed ID: 6133429 [Abstract] [Full Text] [Related]
19. Two kinds of monoclonal antibodies to tick-borne encephalitis virus. Gaidamovich SYa, Melnikova YeE, Gresíková M, Sekeyová M, Novokhatsky AS, Kushch AA, Novák M, Sveshnikova NA, Mikheeva TG, Krasnobayeva ZN. Acta Virol; 1986 May 10; 30(3):206-12. PubMed ID: 2874724 [Abstract] [Full Text] [Related]
20. A live vaccine against tick-borne encephalitis; integrated studies, H. Histopathology of mice peripherally immunized with E5 "14" virus and challenged with virulent virus. Mitrová E, Mayer V. Acta Virol; 1975 May 10; 19(3):219-28. PubMed ID: 239577 [Abstract] [Full Text] [Related] Page: [Next] [New Search]